The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal Women

19991,877 citationsJournal Article

Authors

Among postmenopausal women with osteoporosis, the risk of invasive breast cancer was decreased by 76% during 3 years of treatment with raloxifene.

Good health and well-being

Published in: JAMA

Volume 281, Issue 23, pp. 2189-2189

Field-Weighted Citation Impact: 94.91